e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
COPD: burden of disease, imaging and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late-breaking abstract: Nasal symptoms are common in subjects with COPD and concomitant heart disease
A. Lindberg, L. G. Larsson, E. Rönmark, B. Lundbäck (Umeå, Luleå, Gothenburg, Sweden)
Source:
Annual Congress 2011 - COPD: burden of disease, imaging and management
Session:
COPD: burden of disease, imaging and management
Session type:
Oral Presentation
Number:
2953
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Lindberg, L. G. Larsson, E. Rönmark, B. Lundbäck (Umeå, Luleå, Gothenburg, Sweden). Late-breaking abstract: Nasal symptoms are common in subjects with COPD and concomitant heart disease. Eur Respir J 2011; 38: Suppl. 55, 2953
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Late-breaking abstract: Efficacy of relaxation posture in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
Late-breaking abstract: Comparison of respiratory symptoms in chronic pulmonary obstructive disease and restrictive ventilatory impairment according to disease stage: The PLATINO study in Latin America
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011
Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Heart rhythm disorders in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Late-breaking abstract: HR-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011
COPD is a frequent comorbid condition in patients with chronic heart failure
Source: Annual Congress 2008 - COPD and miscellaneous
Year: 2008
Respiratory symptoms and CRP among participants of the English longitudinal study of ageing (ELSA) – ageing or occult disease?
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
COPD as undetected cause of dyspnea in patients admitted with ischaemic heart disease (IHD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure
Source: International Congress 2014 – Markers
Year: 2014
GOLDs definition of COPD in a Norwegian community by self-reported clinical diagnosis of obstructive lung disease and respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002
The prevelance of chronic nasal symptoms in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002
Late-breaking abstract: Factors associated with medication adherence in patients with COPD
Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Year: 2011
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Small airway disease (SAD) is associated with respiratory symptoms and relevant for therapy in early COPD
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020
How does aerodynamic peculiarities of upper airways influence heart rhythm in severe COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
The most frequent comorbidies in COPD and their inflence on the prognosis of the disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept